Daniel Feinberg Selected Research

PEGylated soluble tumor necrosis factor receptor I

1/2017

TNFα contributes to diabetes impaired angiogenesis in fracture healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Feinberg Research Topics

Disease

6	Multiple Myeloma 11/2023 - 11/2019
1	Venous Thromboembolism 11/2023
1	Neoplasms (Cancer) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Closed Fractures (Closed Fracture) 01/2019
1	Inflammation (Inflammations) 01/2017

Drug/Important Bio-Agent (IBA)

2	sphingosine kinaseIBA 02/2023 - 01/2023
1	fibrin fragment D (D-dimer)IBA 11/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 01/2023
1	B-Cell Activation Factor ReceptorIBA 01/2021
1	PTEN-induced putative kinaseIBA 03/2020
1	Proteasome InhibitorsIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 11/2019
1	ElementsIBA 01/2019
1	Cre recombinaseIBA 01/2019
1	PEGylated soluble tumor necrosis factor receptor IIBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	AntibodiesIBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020